Kantarjian HM - Search Results

1

Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.

O'Brien S, Talpaz M, Cortes J, Shan J, Giles FJ, Faderl S, Thomas D, Garcia-Manero G, Mallard S, Beth M, Koller C, Kornblau S, Andreeff M, Murgo A, Keating M, Kantarjian HM. O'Brien S, et al. Among authors: kantarjian hm. Cancer. 2002 Apr 1;94(7):2024-32. doi: 10.1002/cncr.10436. Cancer. 2002. PMID: 11932905 Free article.

2

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.

Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M. Anaissie E, et al. Ann Intern Med. 1992 Sep 15;117(6):466-9. doi: 10.7326/0003-4819-117-6-466. Ann Intern Med. 1992. PMID: 1354425

3

New drugs in the treatment of chronic lymphocytic leukemia.

Keating MJ, O'Brien S, Robertson L, Plunkett W, Kantarjian H, Koller C. Keating MJ, et al. Leukemia. 1992 Nov;6 Suppl 4:140-1. Leukemia. 1992. PMID: 1359203 No abstract available.

4

Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.

Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Cancer. 1992 Jan 15;69(2):410-2. doi: 10.1002/1097-0142(19920115)69:2<410::aid-cncr2820690222>3.0.co;2-v. Cancer. 1992. PMID: 1370212

5

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Claxton D, Deisseroth A, Talpaz M, Reading C, Kantarjian H, Trujillo J, Stass S, Gooch G, Spitzer G. Claxton D, et al. Blood. 1992 Feb 15;79(4):997-1002. Blood. 1992. PMID: 1371081 Free article.

6

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.

Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ. Robertson LE, et al. Blood. 1992 Jul 1;80(1):29-36. Blood. 1992. PMID: 1377051 Free article.

7

Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individuals.

Seong DC, Gottlieb K, Suh SP, Sims S, Talpaz M, Kantarjian H, Deisseroth A. Seong DC, et al. J Interferon Res. 1992 Oct;12(5):323-7. doi: 10.1089/jir.1992.12.323. J Interferon Res. 1992. PMID: 1431311

8

Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation.

Yuan T, Zhou YQ, Herst CV, Reading C, Ellersen D, Etkin M, Khouri I, Kantarjian H, Talpaz M, Deisseroth A. Yuan T, et al. Prog Clin Biol Res. 1992;377:227-30. Prog Clin Biol Res. 1992. PMID: 1438419 No abstract available.

9

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.

Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S. Lee M, et al. Br J Haematol. 1992 Dec;82(4):708-14. doi: 10.1111/j.1365-2141.1992.tb06948.x. Br J Haematol. 1992. PMID: 1482658

10

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.

Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Lee MS, et al. Blood. 1992 Apr 15;79(8):1920-3. Blood. 1992. PMID: 1562719 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,153 results

Search Page

Filters